3 Topic Commentaries

Optegra Showcases Drop-Free Cataract Surgery Outcomes

Optegra Showcases Drop-Free Cataract Surgery Outcomes

• 

  Stephen T. Armenti, MD, PhD

  Ophthalmology (Cataract/Cornea)

  •

  University of Pennsylvania, Scheie Eye Institute

  Sub-Tenon’s TA was noninferior to topical steroids in terms of incidence of IOP spikes, CMO, and rebound iritis following cataract surgery.

  Source
• 

  Nikolaos Dervenis, MD, MSc, FEBO

  Ophthalmology

  •

  University of Liverpool

  While intracameral antibiotics achieve adequate bactericidal concentrations in the anterior chamber, they are unlikely to provide adequate antibiotic levels on the ocular surface.

  Source
• 

  Toni Golen, MD

  Obstetrics and Gynecology

  •

  Harvard Health Publishing (Harvard Medical School)

  Recently, however, eye surgeons have been able to administer a medication into the eye during cataract surgery that eliminates the need for drops afterward.

  Source